Commonwealth Equity Services, LLC Gossamer Bio, Inc. Transaction History
Commonwealth Equity Services, LLC
- $75.7 Billion
- Q2 2025
A detailed history of Commonwealth Equity Services, LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 35,271 shares of GOSS stock, worth $80,065. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,271
Previous 42,116
16.25%
Holding current value
$80,065
Previous $46,000
6.52%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding GOSS
# of Institutions
140Shares Held
159MCall Options Held
2.89MPut Options Held
130K-
Octagon Capital Advisors LP New York, NY18.4MShares$41.7 Million8.57% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$41.1 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$25.9 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$18.3 Million5.25% of portfolio
-
Acadian Asset Management LLC Boston, MA7.15MShares$16.2 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $213M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...